CL2019000846A1 - Proteína terapéutica. - Google Patents

Proteína terapéutica.

Info

Publication number
CL2019000846A1
CL2019000846A1 CL2019000846A CL2019000846A CL2019000846A1 CL 2019000846 A1 CL2019000846 A1 CL 2019000846A1 CL 2019000846 A CL2019000846 A CL 2019000846A CL 2019000846 A CL2019000846 A CL 2019000846A CL 2019000846 A1 CL2019000846 A1 CL 2019000846A1
Authority
CL
Chile
Prior art keywords
therapeutic protein
therapy
deflamin
nutraceutical
cancer
Prior art date
Application number
CL2019000846A
Other languages
English (en)
Inventor
Ana Isabel Gusmão Lima
Joana Patrícia Mota Guerreiro
Ricardo Manuel De Seixas Boavida Ferreira
Original Assignee
Inst Superior Agronomia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PT109645A external-priority patent/PT109645A/pt
Priority claimed from GBGB1616715.7A external-priority patent/GB201616715D0/en
Application filed by Inst Superior Agronomia filed Critical Inst Superior Agronomia
Publication of CL2019000846A1 publication Critical patent/CL2019000846A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/168—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/185—Vegetable proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/30—Extraction; Separation; Purification by precipitation
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/308—Foods, ingredients or supplements having a functional effect on health having an effect on cancer prevention
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/324—Foods, ingredients or supplements having a functional effect on health having an effect on the immune system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/31—Extraction of the material involving untreated material, e.g. fruit juice or sap obtained from fresh plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

UNA COMPOSICIÓN DE POLIPÉPTIDO DE DEFLAMINA PARA USO EN UN MÉTODO DE TRATAMIENTO DEL CUERPO HUMANO O ANIMAL MEDIANTE TERAPIA EN DONDE LA TERAPIA PREFERIBLEMENTE PREVIENE O TRATA LA INFLAMACIÓN O EL CÁNCER, O PROPORCIONA UN NUTRACÉUTICO.
CL2019000846A 2016-09-30 2019-03-29 Proteína terapéutica. CL2019000846A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PT109645A PT109645A (pt) 2016-09-30 2016-09-30 Composição de polipéptidos da deflamina, sua utilização num método de tratamento e sua preparação, vetores de ácido nucleico que a expressam e anticorpo para aqueles polipéptidos
GBGB1616715.7A GB201616715D0 (en) 2016-09-30 2016-09-30 Therapeutic protein

Publications (1)

Publication Number Publication Date
CL2019000846A1 true CL2019000846A1 (es) 2019-11-15

Family

ID=60582543

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2019000846A CL2019000846A1 (es) 2016-09-30 2019-03-29 Proteína terapéutica.

Country Status (14)

Country Link
US (1) US20200113969A1 (es)
EP (1) EP3518957B1 (es)
JP (1) JP2020503060A (es)
KR (1) KR20190061015A (es)
CN (1) CN110214017A (es)
AU (1) AU2017334047A1 (es)
BR (1) BR112019006174A2 (es)
CA (1) CA3037800A1 (es)
CL (1) CL2019000846A1 (es)
CO (1) CO2019003865A2 (es)
IL (1) IL265708A (es)
MX (1) MX2019003751A (es)
WO (1) WO2018060528A2 (es)
ZA (1) ZA201902689B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7304053B2 (ja) * 2019-02-15 2023-07-06 国立大学法人金沢大学 肝臓がん発症リスクの判定方法、及び肝臓がん発症リスクの判定キット
CN112772843A (zh) * 2021-01-27 2021-05-11 上海理工大学 一种适用于ibd炎症性肠病患者食用的代餐粉及其制备方法
CN112753943A (zh) * 2021-01-27 2021-05-07 上海理工大学 一种具有炎症性肠病调节功能的能量棒及其制作方法
CN114106083A (zh) * 2021-12-09 2022-03-01 南开大学 一种小米蛋白和小米蛋白水解物的制备方法及小米蛋白水解物的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20041308A1 (it) * 2004-06-29 2004-09-29 Fraunhofer Ges Zur Foerderung... Processo per la purificazione da seme di lupiom di frazioni proteiche attive sul metabolismo lipidico
SI2333086T1 (sl) * 2005-07-21 2015-07-31 Instituto Superior De Agronomia Uporaba Lupinus proteina
CA2688464C (en) * 2007-06-01 2016-04-12 Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of Agriculture And Agri-Food A process of aqueous protein extraction from brassicaceae oilseeds
US8609161B2 (en) * 2008-05-30 2013-12-17 Ospedale San Raffaele S.R.L. Conglutin-gamma as medicament and diet supplement
SG189379A1 (en) * 2010-10-12 2013-05-31 Consumo Em Verde Biotecnologia Das Plantas S A Antimicrobial protein

Also Published As

Publication number Publication date
MX2019003751A (es) 2019-12-16
US20200113969A1 (en) 2020-04-16
WO2018060528A2 (en) 2018-04-05
ZA201902689B (en) 2019-11-27
IL265708A (en) 2019-05-30
WO2018060528A3 (en) 2018-07-05
KR20190061015A (ko) 2019-06-04
JP2020503060A (ja) 2020-01-30
BR112019006174A2 (pt) 2019-06-18
CA3037800A1 (en) 2018-04-05
AU2017334047A1 (en) 2019-05-16
EP3518957A2 (en) 2019-08-07
CN110214017A (zh) 2019-09-06
CO2019003865A2 (es) 2019-04-30
EP3518957B1 (en) 2024-05-15

Similar Documents

Publication Publication Date Title
CL2018001152A1 (es) Composiciones y métodos para el tratamiento del cáncer
CR20190376A (es) Formulaciones de anticuerpos de her2 subcutáneas
CL2019000846A1 (es) Proteína terapéutica.
CO2018014010A2 (es) Anticuerpos a la alfa-sinucleína y usos de los mismos
CO2017005784A2 (es) Compuestos bicíclicos fusionados para el tratamiento de enfermedades
BR112017018954A2 (pt) uso de forma mutante de proteína ras e método para tratar câncer
BR112018013731A2 (pt) combinações anti-egfr para o tratamento de tumores
BR112017019738A2 (pt) macrociclos peptidomiméticos e usos dos mesmos
CO2017007121A2 (es) Compuestos bicíclicos fusionados para el tratamiento de enfermedades
SV2017005373A (es) Inhibidores de la proteína quinasa c y métodos de su uso
MX2022008868A (es) Tratamiento del cancer con tg02.
BR112017018964A2 (pt) uso de plinabulin e métodos para tratar tumor cerebral
CL2019002368A1 (es) Composiciones y métodos para el tratamiento de cáncer.
BR112017023517A2 (pt) anticorpo anti-cd20 para tratamento do câncer, composição farmacêutica, método de tratamento de um paciente que sofre de câncer e uso de um anticorpo anti-cd20
BR112015026247A2 (pt) métodos para o tratamento de câncer com o uso de terapia combinada com inibidor de cinase tor
CY1123501T1 (el) Χρηση ρεσλιζουμαμπης για τη θεραπευτικη αντιμετωπιση μετριου εως σοβαρου ηωσινοφιλικου ασθματος
CY1123366T1 (el) Παραγωγα 8-αμινο-2-οξο-1,3-διαζα-σπειρο-[4.5]-δeκανιου
MX2020001727A (es) Terapia de combinacion.
MX2022002056A (es) Compuestos para el tratamiento de enfermedad respiratoria bovina o porcina.
BR112017025533A2 (pt) método para tratar câncer em um paciente humano
BR112018002530A2 (pt) combinações e usos e tratamentos destas
CY1122882T1 (el) Παραγωγα 3-(καρβοξυαιθυλ)-8-αμινο-2-οξο-1,3-διαζα-σπειρο-[4.5]-δεκανιου
CO2020001107A2 (es) Moduladores terapéuticos del modo inverso de la atp sintasa
EP3991749A3 (en) A therapeutic agent for a tumor comprising an ido inhibitor administered in combination with an antibody
MX2017010341A (es) Terapia para cancer con un parvovirus combinado con bevacizumab.